Surgical management of pleuropulmonary tuberculosis.

Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Surgical management of pleuropulmonary tuberculosis.

J Thorac Cardiovasc Surg. 1996 Mar;111(3):662-70. Unique Identifier : AIDSLINE MED/96176936
Mouroux J; Maalouf J; Padovani B; Rotomondo C; Richelme H; Service de Chirurgie Abdominale et Thoracique, Hopital Pasteur,; Nice, France.

Abstract: To define the current indications for surgical management of pleuropulmonary tuberculosis and analyze the results of operative procedures, the records of 59 patients operated on between January 1987 and December 1993 were reviewed. Three patient categories were defined. Group I patients (n = 25) underwent operation for diagnostic purposes: solitary mediastinal node or mediastinal adenopathy associated with pulmonary lesions (n = 10), pulmonary infiltrates (n = 4), pulmonary nodules or masses (n = 10), or chronic pleurisy (n = 1). Postoperative mortality and morbidity rates in this group were both 4%. Group II patients (n = 18) underwent operation for active lesions: intrapulmonary cavity (n = 6), destroyed lung parenchyma (n = 6), or chronic loculated pleural effusion (n = 6). Postoperative morbidity and mortality rates were 16.6% and 5.5%, respectively. Group III patients (n = 16) underwent operation for a complication of therapy or for sequelae of previously cured tuberculosis: calcified pyothorax (n = 8), empyema (n = 2), fistulized nodes (n = 2), bronchiectasis (n = 3), or aspergilloma (n = 1). Morbidity and mortality rates in this group were 31.25% and 12.5%, respectively. Surgery continues to have both diagnostic and therapeutic indications for management of pleuropulmonary tuberculosis, despite the morbidity and mortality rates associated with operative procedures.

Keywords: Adolescence Adult Africa/EPIDEMIOLOGY Aged Aged, 80 and over Asia, Southeastern/EPIDEMIOLOGY Combined Modality Therapy Comparative Study Female Follow-Up Studies France/EPIDEMIOLOGY Human HIV Seropositivity/DIAGNOSIS/IMMUNOLOGY HIV-1/IMMUNOLOGY Male Middle Age Pneumonectomy Retrospective Studies Thoracotomy Tuberculosis, Pleural/COMPLICATIONS/DIAGNOSIS/MORTALITY/*SURGERY Tuberculosis, Pulmonary/COMPLICATIONS/DIAGNOSIS/MORTALITY/ *SURGERY JOURNAL ARTICLE
960730
M9670444

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .